Aldeyra Therapeutics Inc (ALDX) went up 16.90% yesterday: Is this the Most Sought-After Stock Today?

Aldeyra Therapeutics Inc (NASDAQ: ALDX) open the trading on Wednesday, with great promise as it jumped 16.90% to $4.15, before settling in for the price of $3.55 at the close. Taking a more long-term approach, ALDX posted a 52-week range of $1.42-$11.97.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 0.00%. Meanwhile, its Annual Earning per share during the time was 18.70%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 81.30%. This publicly-traded company’s shares outstanding now amounts to $59.20 million, simultaneously with a float of $56.55 million. The organization now has a market capitalization sitting at $244.44 million. At the time of writing, stock’s 50-day Moving Average stood at $3.32, while the 200-day Moving Average is $4.78.

Aldeyra Therapeutics Inc (ALDX) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Aldeyra Therapeutics Inc’s current insider ownership accounts for 3.98%, in contrast to 59.51% institutional ownership. According to the most recent insider trade that took place on Apr 03 ’24, this organization’s 10% Owner bought 309,847 shares at the rate of 4.09, making the entire transaction reach 1,267,274 in total value, affecting insider ownership by 9,097,858. Preceding that transaction, on Apr 02 ’24, Company’s 10% Owner bought 186,051 for 3.44, making the whole transaction’s value amount to 640,015. This particular insider is now the holder of 8,788,011 in total.

Aldeyra Therapeutics Inc (ALDX) Earnings and Revenue Records

So, what does the last quarter earnings report of the company that was made public on 12/30/2023 suggests? It has posted -$0.08 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.14) by $0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.

Aldeyra Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 81.30% and is forecasted to reach -0.38 in the upcoming year.

Aldeyra Therapeutics Inc (NASDAQ: ALDX) Trading Performance Indicators

Let’s observe the current performance indicators for Aldeyra Therapeutics Inc (ALDX). It’s Quick Ratio in the last reported quarter now stands at 6.44. The Stock has managed to achieve an average true range (ATR) of 0.25.

In the same vein, ALDX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.64, a figure that is expected to reach -0.11 in the next quarter, and analysts are predicting that it will be -0.38 at the market close of one year from today.

Technical Analysis of Aldeyra Therapeutics Inc (ALDX)

[Aldeyra Therapeutics Inc, ALDX] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 87.69% While, its Average True Range was 0.28.

Raw Stochastic average of Aldeyra Therapeutics Inc (ALDX) in the period of the previous 100 days is set at 91.12%, which indicates a major fall in contrast to 95.36% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 74.17% that was lower than 83.76% volatility it exhibited in the past 100-days period.